3.48 The Predictive Value of High Tumor Mutational Burden with Dr. Luc Morris
- Author
- [email protected] (Vinay Prasad, MD MPH)
- Published
- Sat 06 Mar 2021
- Episode Link
- https://soundcloud.com/plenarysession/ep348
Today we interview Dr. Luc Morris of Memorial Sloan Kettering Cancer Center on his new paper out now in JAMA Oncology titled "Response Rates to Anti-PD-1 Immunotherapy in Microsatellite-Stable Solid Tumors With 10 or More Mutations per Megabase".
Response Rates: doi.org/10.1001/jamaoncol.2020.7684
Back us on Patreon! www.patreon.com/plenarysession
Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew
